ResMed Inc
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$242.61+4.76 (+2.00%)
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Global Devices Revenue: $720M in Q1 FY27, up 5.9% from a year earlier.
Latest, Q1 FY27
720
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
+5.9%
680 in Q1 FY26
History
25 quarters
Since Q1 FY21
Sources
20
Documents cited below
Where the Q1 FY27 figure comes from
Source: ResMed SEC Filing (0000943819-26-000089) ↗
Reported in ResMed Form 10-K/10-Q Segment Disclosures & Form 8-K Revenue by Product and Region Tables.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up global Devices Revenue
- Global Devices — Revenue Growth YoY (%)6.0% · Q1 FY27
- Global Devices — Constant Currency Growth YoY (%)6.0% · Q1 FY27
- Global Devices — Share of Trailing 12-Month Consolidated Revenue (%)–
- Global Devices — Share of Quarterly Consolidated Revenue (Legacy through FY2026Q3, %)51.0% · Q3 FY26
- Americas Devices Revenue ($M)436 · Q1 FY27
- Rest of World Devices Revenue ($M)284 · Q1 FY27
Cite this data
StockData. (2026). ResMed Global Devices Revenue ($M), quarterly Q1 FY21–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-rev
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?